Sources and updates, May 8
Sources and updates for the week of May 8 include booster shots, vaccine attitudes, wastewater data, and source diversity.
Read MoreCategory: Vaccines
The US still doesn’t have the data we need to make informed decisions on booster shots
Last fall, I wrote that the U.S. did not have the data we needed to make informed decisions about booster shots. Several months later, we still don’t have the data we need, as questions about a potential BA.2 wave and other future variants abound. Discussions at a recent FDA advisory committee meeting made these data gaps clear.
Read MoreSources and updates, March 13
Sources and updates for the week of March 13 include vaccine data annotations, free rapid tests, a combination of Delta and Omicron, and more.
Read MorePandemic preparedness: Improving our data surveillance and communication
What has the U.S. learned from the last two years, and what lessons can we take forward for future COVID-19 surges and other infectious disease outbreaks? The Biden administration has released a new pandemic preparedness plan that addresses these questions.
Read MoreAs COVID-19 precautions are lifted, who remains vulnerable?
As more states and other institutions lift COVID-19 safety measures, the shift has sparked a conversation about who remains most vulnerable to COVID-19 during this period. These vulnerable groups include unvaccinated and unboosted seniors, immunocompromised people, and pregnant people.
Read MoreOmicron updates: BA.2, vaccine effectiveness, and more
Omicron updates for the week of February 13 include BA.2 estimates, vaccine effectiveness from a booster shot, COVID-19 in deer, and more.
Read MoreOmicron updates: The continued importance of vaccination
Omicron updates this week include BA.2’s transmissibility, the importance of vaccination to protect against severe symptoms, and the U.S.’s high death toll.
Read MoreWe failed to vaccinate the world in 2021; will 2022 be more successful?
In January, COVAX set a goal that many global health advocates considered modest: delivering 2.3 billion vaccine doses to low- and middle-income countries by the end of 2021. is saying it’ll deliver just 800 million vaccine doses by the end of 2021, according to the Washington Post, and only about 600 million had been delivered by early December.
Read MoreOne month into vaccinations for kids 5-11, uptake varies wildly by state
It’s been about a month since the FDA and CDC authorized a version of Pfizer’s vaccine for children ages five to 11. Those kids whose parents immediately took them to get vaccinated are now eligible for their second doses, and will be considered fully vaccinated by Christmas. Despite widespread availability of the shots, vaccine uptake has varied wildly.
Read MoreOmicron updates: More transmissible, immune evading, but still not cause for panic
We continue to learn more about this new variant as it spreads rapidly across the world, though much of the data are still preliminary. Here are a few major updates, including how vaccines fare against Omicron, its rapid spread, and more.
Read More